|
|||||
|
|
||||||
Journal of Clinical Oncology, Vol 23, No 22 (August 1), 2005: pp. 4945-4953 © 2005 American Society of Clinical Oncology. DOI: 10.1200/JCO.2005.03.475 Persistence of Restrictions in Quality of Life From the First to the Third Year After Diagnosis in Women With Breast CancerFrom the Department of Epidemiology, German Centre for Research on Ageing, Heidelberg; Department of Epidemiology, University of Ulm, Ulm; and Saarland Cancer Registry, Saarbrücken, Germany Address reprint requests to Volker Arndt, MD, MPH, German Centre for Research on Ageing (DZFA), Department of Epidemiology, Bergheimer Strasse 20, D-69115 Heidelberg, Germany; e-mail: arndt{at}dzfa.uni-heidelberg.de PURPOSE: To assess whether detriments in quality of life (QOL) among women with breast cancer persist over years. PATIENTS AND METHODS: QOL was assessed in a population-based cohort of 314 women with breast cancer from Saarland (Germany) 1 and 3 years after diagnosis and compared internally and with reference data from the general population. RESULTS: Three years after diagnosis, deficits in QOL were still apparent for role, emotional, cognitive, and social functioning and for the symptoms of insomnia, fatigue, dyspnea, and financial difficulties. Differences between breast cancer patients and women from the general population were predominantly found in younger ages. Compared with the QOL scores measured 1 year after diagnosis, only minor functional changes were observed, but recurrence of breast cancer during the follow-up interval had a deleterious effect on QOL. CONCLUSION: Deficits in role, emotional, cognitive, and social functioning persist over years in women with breast cancer and predominantly affect younger patients. Supported by two grants from the German Cancer Foundation (Deutsche Krebshilfe), project No. 70-1816 and 70-2413. Presented in part at the 26th Annual Meeting of the International Association of Cancer Registries, Beijing, China, September 14-16, 2004. Authors disclosures of potential conflicts of interest are found at the end of this article. This article has been cited by other articles:
|
||||||||||||||||||||||||
|
|||||||||||
|
Copyright © 2005 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
|